WELCOME TO ANPA - YOUR INTELLECTUAL PROFESSIONAL HOME

HOW TO USE THE MEETING Q&A FUNCTION


IMPORTANT INFORMATION!

CHANGES FOR 2022!

When you register for the 32nd Annual Meeting, you'll notice that there is no longer a cost associated with the Pre-Meeting Symposia!  In past years, there were separate costs for Neuropsychiatry 101 and the Daniel Kaufer, MD Symposia.  In 2022, you'll only be charged one cost and that includes the pre-meetings as well as the main portion of the conference.  This is a major savings.

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The Executive Committee of the ANPA had concerns that residents of emerging countries could not afford to attend the conference; therefore, those residents will be charged the Trainee Rate.  Please note those claiming to be a resident of a qualified country will need a code to register; please e-mail the Administrative Director at mailto:anpaoffice@gmail.com for your code.  Be sure to indicate which country you are a resident of.  See the listing of qualified countries here: Developing Countries List.pdf


MEETING AGENDA

All times shown are Eastern Time Zone

(Subject to Change)

VERY IMPORTANT NOTE!

The formatting for the 2022 meeting will be very different than prior years.  Each day, the listed lectures will be released at 6:00 a.m. EDT.  Meeting registrants will be able to view the lectures at convenient times during the day but PRIOR TO 5:00 P.M. WHEN THE Q&A SESSIONS BEGIN.  The lectures for the day will be taken down after the end of the last Q&A session.  Viewing of the lectures each day will be credited towards live CME.   The lectures will then be available for “on-demand” viewing and CME after the end of the conference.

Wednesday, March 16, 2022

Neuropsychiatry of the Placebo Response

Donald Eknoyan, MD                     The Placebo Response in Medicine: The History and Observations

Fabrizio Benedetti, MD                 The placebo effect: how words and drugs share a common mechanism of action

Ted Kaptchuk, MD                           Placebo Effects in Medicine

DANIEL J. KAUFER SYMPOSIUM – SOCIAL COGNITION & WHITE MATTER

Christopher Filley,MD                    Case Presentation

Isaiah Kletenik, MD                        Criminal Networks: linking the human connectome to the transcriptome

Christopher Filley, MD                    Social Cognition, White Matter, and the Neural Basis of Morality

SIG PRESENTATION - FUNCTIONAL NEUROLOGICAL DISORDER - A CORE NEUROPSYCHIATRIC CONDITION

David Perez, MD                             The Neuropsychiatric Assessment of Functional Neurological Disorder

W. Curt LaFrance, MD                   Treatments for Functional Neurological Disorder

Selma Aybeck, MD                          The Emerging Pathophysiology of Functional Neurological Disorder

LIVE Q&A

5:00 p.m.                                          Neuropsychiatry of the Placebo Response

5:15 p.m.                                           Social Cognition & White Matter

5:30 p.m.                                           Functional Neurological Disorder    

 NEW!  OPENING NIGHT SOCIAL HOUR - DROP IN TO VISIT! 

6:00 pm LIVE - Join your colleagues for a social hour.  Link to be posted at conference.                 

                 

6:30 p.m.                              Advisory Committee – Invitation Only

---------------------------------------------------------------------------------------------------------------------------------------------------

THURSDAY, MARCH 17, 2022

SESSION 1 - SLEEP AND BRAIN HEALTH

M. Brandon Westover, MD          Measuring Brain Health Through Sleep

Dara Manoach Ph.D.                      Targeting sleep oscillations to improve memory in neurodevelopmental disorders

Laura Lewis, Ph.D.                          Imaging the Consequences of Sleep for the Brain

PLATFORM PRESENTATIONS

Clinical Platforms - Hosted by Michael Schrift, DO, MA, FANPA

Nikita Jain 

Subclinical Seizures and Postictal Catatonia in a Case of Reversible Rapidly Progressive Dementia

A. Fesharaki-Zadeh

A case of possible Chronic Traumatic Encephalopathy comorbid with Alzheimer’s Disease in an ex-football player 

Gabriela Austgen

Anti-NMDA Receptor Encephalitis in a Patient with Relapsing Polychondritis

Damek Homiack

Catatonia in Maternal Duplication 15q11-13 Syndrome with Autism Spectrum Disorder Successfully Treated with Electroconvulsive Therapy 

Rishab Gupta

Benzodiazepine-dependent Recurrent Catatonia: A rare entity 

Brant Thayer

Clinical and Legal Challenges in Distinguishing Hepatic Encephalopathy from Bipolar Mania in an Involuntary Treatment Setting



Research Platforms - Hosted by David Perez, MD, FANPA

Deepti Verma

Analyzing the Current State of Sleep Apps in the App Marketplace and in Literature: A Systematic Review.


Annaliese Elmer - 

Factor Structure of the Neurobehavioral Symptom Inventory in a Veteran-Predominant Cohort with

Persisting Symptoms after Mild Traumatic Brain Injury and Co-Occurring Psychological Health Conditions 

Sepideh Bajestan

A Web-Based Educational Module Using Clinical Neuroscience to Deliver the Diagnosis of Functional Neurological Disorder 

Kevin Black, MD

A Masked, Controlled Trial of Median Nerve Stimulation for Tourette Syndrome

N. Thovinakere

Effects of Smoking Behaviour Change on Resting-State Functional Connectivity: Insights from a Prospective

Longitudinal Cohort

Ana Maria Rivas-Grajales

Electroconvulsive Therapy Leads to Plastic Changes in the Medial Forebrain Bundle Associated with

Improvement in Anhedonia and Depression Severity


CLINICAL PRACTICE WORKSHOP 1

Paula Trzepacz, MD                        Three Core Domains and the Delirium Diagnostic Test - Provisional (DDT-Pro)

NEW - JOIN YOUR COLLEAGUES FOR BRUNCH!  LIVE!

At 9 a.m. Pacific and 12 noon Eastern time, bring your breakfast or lunch to this LIVE social gathering!  Link to be posted at the conference


LIVE Q&A

5:00 p.m.                                          Sleep & Brain Health

5:30 p.m.                                           Delirium Assessment

5:45 p.m.     Platform Discussion/Questions

POSTER SESSION – 6:00 – 8:00 p.m.

-------------------------------------------------------------------------------------------------------------------------------------------------------

FRIDAY, MARCH 18, 2022

PRESIDENTIAL SYMPOSIUM - THE GUT-BRAIN AXIS IN NEUROPSYCHIATRIC DISEASES

Alessio Fasano, MD                        Pathophysiology of the bidirectional communication between gut and brain 

Sarkis Mazmanian, Ph.D.              How gut microbiome regulates motor deficits and neuroinflammation

                                                            in Parkinson’s  disease

Tatiana Barichello, Ph.D.               The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology

James Adams, Ph.D.                       Manipulation of the gut microbiome by fecal microbiota transplant in autism

                                                            spectrum disorders

SESSION 2 Exploring the Human Connectome as a Clinician

Shan Siddiqi, MD                             Introduction: tools for exploring the human connectome

Aaron Boes, MD                              Personalized Prognostication after Stroke

Andreas Horn, MD                          Connectomic DBS

Shan Siddiqi, MD                             Connectomic TMS

LIVE Q&A

5:00 p.m.                                          The Gut-Brain Axis in Neuropsychiatric Diseases

5:30 p.m.                                           Exploring the Human Connectome as a Clinician

ANPA NEUROPSYCHIATRY BAZAAR – 6:00 – 7:30 p.m. - LIVE EVENT!

-----------------------------------------------------------------------------------------------------------------------------------------------------

SATURDAY, MARCH 19, 2022

BASSOE LECTURE

Edward Chang, MD                         Restoring words: Towards a Speech Neuroprosthesis

SPECIAL LECTURE - GLOBAL NEUROPSYCHIATRY

Bizu Gelaye, Ph.D.                            Neuropsychiatric Genetics of African Populations (NEUROGAP):  A multi-country

                                                            research and training program

COMMITTEE ON RESEARCH (CoR)

Gaston Baslet, MD                          The Role of Neuropsychiatry in the Post-Acure Sequelae of COVID-19 (PASC)

PRESIDENT’S ADDRESS

Kaloyan Tanev, MD                        Cognitive Examination via Telehealth

CLINICAL PRACTICE WORKSHOP 2

Sara Mitchell, MD                           Dementia care during the pandemic and beyond

NEW!  BACK BY POPULAR DEMAND!  MAGICIAN DANIEL ROY!

Join us LIVE at 4:00 p.m. Eastern Time with Magician DANIEL ROY!  Link to be posted at conference


LIVE Q&A

5:00 p.m.                                          Bassoe Lecture

5:15 p.m.                                           Global Neuropsychiatry

5:30 p.m.                                           President’s Address

5:45 p.m.                                           CoR

6:00 p.m.    Clinical Practice Workshop 2

AWARDS & NEW ANPA FELLOWS

--------------------------------------------------------------------------------------------------------------------------------------------------------

SUNDAY, MARCH 20, 2022

11:00 a.m EDT                                 Business Meeting (Zoom Call)

                                                            https://us02web.zoom.us/j/86882573156?pwd=eVdycXpwaisrZkFlUFNROU8vZjlWUT09

 

The Medical University of South Carolina Office of Continuing Medical Education has reviewed and approved your application for a maximum of 29.0 AMA PRA Category 1 CreditsTM.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical University of South Carolina and the American Neuropsychiatric Association. The Medical University of South Carolina is accredited




**  The Peter Bassoe Lecture

Dr. Peter Bassoe (1874-1945) was a Chicago-based neurologist-neuropsychiatrist as well as the founder and inaugural President of the Central Neuropsychiatric Association (CNPA, est. 1922). Dr. Bassoe founded the CNPA “to foster the advancement of neurologic, neurosurgical, and psychiatric sciences in the mid-continental United States.” Guided by his vision, this organization flourished during the decades of the mid-twentieth century. The Peter Bassoe Fund was established within the CNPA in 1982 for the purpose of providing funds for continuing education activities, scholarships, awards for essays submitted by residents, and other expenses of the scientific portion of the meeting.

In 2001, following several decades of changes to the organizational and political landscape in the clinical neurosciences, CNPA merged with ANPA. As a component of the merger agreement between our associations, CNPA directed ANPA to use the Bassoe Fund to support a Keynote Address at the ANPA annual meeting and to identify it as the Peter Bassoe Lecture.

In tribute to Dr. Bassoe and CNPA, the Peter Bassoe Lecture is given by a world-class clinical neuroscientist at  the ANPA Annual Meeting. The lecture provides a forum for a high-level review in the area of neuroscience to which the Peter Bassoe Lecturer has contributed. Additionally, it provides an opportunity for the lecturer to discuss the implications of his or her work on the education and training of clinician-neuroscientists, including subspecialists in behavioral neurology & neuropsychiatry.

Accreditation

The Medical University of South Carolina Office of Continuing Medical Education will provide CME and CE accreditation for this program.




    Exhibitor Opportunities

    The ANPA meeting provides an excellent opportunity for service providers, publishers, and members of industry to encounter national leaders in neuropsychiatric and neurobehavioral theory and practice through sponsorship opportunities that utilizing the virtual Exhibit Hall.  Supporter opportunities will be published soon.

    Supporter materials and exhibits must be non-political and shall not be offensive to public decency on either a local or international basis. The character of exhibits is subject to the approval of the ANPA Administrative Director and Executive Committee. 

    Applications for exhibitors are subject to review by the ANPA Administrative Director and Executive Committee to determine suitability for the meeting and to ensure conformity with conventional standards.

    Please contact the Administrative Director at anpaoffice@gmail.com for information


    TERMS OF USE  PRIVACY

    © 2016 American Neuropsychiatric Association (ANPA). All rights reserved.

    PO Box 97 Abilene, KS 67410-1707. anpaoffice@gmail.com